Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection

Amel Ahmed, Lei Lei Wang, Safaa Abdelmaksoud, Amal Aboelgheit, Safaa Saeed, Chun Li Zhang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Retinal ischemia-reperfusion (IR) injury causes irreversible loss of neurons and ultimately leads to permanent visual impairment and blindness. The cellular response under this pathological retinal condition is less clear. Using genetically modified mice, we systematically examined the behavior of microglia/macrophages after injury. We show that IR leads to activation of microglia/macrophages indicated by migration and proliferation of resident microglia and recruitment of circulating monocytes. IR-induced microglia/macrophages associate with apoptotic retinal neurons. Very interestingly, neuron loss can be mitigated by minocycline treatment. Minocycline induces Il4 expression and M2 polarization of microglia/macrophages. IL4 neutralization dampens minocycline-induced M2 polarization and neuroprotection. Given a well-established safety profile as an antibiotic, our results provide a rationale for using minocycline as a therapeutic agent for treating ischemic retinal degeneration.

Original languageEnglish (US)
Article number14065
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Retinal Degeneration
Minocycline
Microglia
Reperfusion
Ischemia
Macrophages
Retinal Neurons
Neurons
Macrophage Activation
Vision Disorders
Blindness
Reperfusion Injury
Interleukin-4
Monocytes
Neuroprotection
Anti-Bacterial Agents
Safety
Wounds and Injuries

ASJC Scopus subject areas

  • General

Cite this

Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection. / Ahmed, Amel; Wang, Lei Lei; Abdelmaksoud, Safaa; Aboelgheit, Amal; Saeed, Safaa; Zhang, Chun Li.

In: Scientific Reports, Vol. 7, No. 1, 14065, 01.12.2017.

Research output: Contribution to journalArticle

Ahmed, Amel ; Wang, Lei Lei ; Abdelmaksoud, Safaa ; Aboelgheit, Amal ; Saeed, Safaa ; Zhang, Chun Li. / Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{d810b263a5c446bc8292600edfebe6c1,
title = "Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection",
abstract = "Retinal ischemia-reperfusion (IR) injury causes irreversible loss of neurons and ultimately leads to permanent visual impairment and blindness. The cellular response under this pathological retinal condition is less clear. Using genetically modified mice, we systematically examined the behavior of microglia/macrophages after injury. We show that IR leads to activation of microglia/macrophages indicated by migration and proliferation of resident microglia and recruitment of circulating monocytes. IR-induced microglia/macrophages associate with apoptotic retinal neurons. Very interestingly, neuron loss can be mitigated by minocycline treatment. Minocycline induces Il4 expression and M2 polarization of microglia/macrophages. IL4 neutralization dampens minocycline-induced M2 polarization and neuroprotection. Given a well-established safety profile as an antibiotic, our results provide a rationale for using minocycline as a therapeutic agent for treating ischemic retinal degeneration.",
author = "Amel Ahmed and Wang, {Lei Lei} and Safaa Abdelmaksoud and Amal Aboelgheit and Safaa Saeed and Zhang, {Chun Li}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-14450-5",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Minocycline modulates microglia polarization in ischemia-reperfusion model of retinal degeneration and induces neuroprotection

AU - Ahmed, Amel

AU - Wang, Lei Lei

AU - Abdelmaksoud, Safaa

AU - Aboelgheit, Amal

AU - Saeed, Safaa

AU - Zhang, Chun Li

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Retinal ischemia-reperfusion (IR) injury causes irreversible loss of neurons and ultimately leads to permanent visual impairment and blindness. The cellular response under this pathological retinal condition is less clear. Using genetically modified mice, we systematically examined the behavior of microglia/macrophages after injury. We show that IR leads to activation of microglia/macrophages indicated by migration and proliferation of resident microglia and recruitment of circulating monocytes. IR-induced microglia/macrophages associate with apoptotic retinal neurons. Very interestingly, neuron loss can be mitigated by minocycline treatment. Minocycline induces Il4 expression and M2 polarization of microglia/macrophages. IL4 neutralization dampens minocycline-induced M2 polarization and neuroprotection. Given a well-established safety profile as an antibiotic, our results provide a rationale for using minocycline as a therapeutic agent for treating ischemic retinal degeneration.

AB - Retinal ischemia-reperfusion (IR) injury causes irreversible loss of neurons and ultimately leads to permanent visual impairment and blindness. The cellular response under this pathological retinal condition is less clear. Using genetically modified mice, we systematically examined the behavior of microglia/macrophages after injury. We show that IR leads to activation of microglia/macrophages indicated by migration and proliferation of resident microglia and recruitment of circulating monocytes. IR-induced microglia/macrophages associate with apoptotic retinal neurons. Very interestingly, neuron loss can be mitigated by minocycline treatment. Minocycline induces Il4 expression and M2 polarization of microglia/macrophages. IL4 neutralization dampens minocycline-induced M2 polarization and neuroprotection. Given a well-established safety profile as an antibiotic, our results provide a rationale for using minocycline as a therapeutic agent for treating ischemic retinal degeneration.

UR - http://www.scopus.com/inward/record.url?scp=85032280503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032280503&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-14450-5

DO - 10.1038/s41598-017-14450-5

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 14065

ER -